MAM
SER icon

Meeder Asset Management’s Serina Therapeutics SER Stock Holding History

Meeder Asset Management’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3
Closed – – 2401
2021
Q3 		$0 Hold
3
– – ﹤0.01% 2664
2021
Q2 		$0 Hold
3
– – ﹤0.01% 2691
2021
Q1 		$0 Buy
+3
New +$210 ﹤0.01% 2475
2020
Q4 		– Sell
-3
Closed – – 2265
2020
Q3 		$0 Hold
3
– – ﹤0.01% 2407
2020
Q2 		$0 Hold
3
– – ﹤0.01% 2525
2020
Q1 		$0 Sell
3
-28
-90% -$1.32K ﹤0.01% 2569
2019
Q4 		$2K Buy
31
+13
+72% +$702 ﹤0.01% 2074
2019
Q3 		$1K Buy
18
+5
+38% +$474 ﹤0.01% 2101
2019
Q2 		$2K Hold
13
– – ﹤0.01% 1890
2019
Q1 		$2K Sell
13
-3
-19% -$439 ﹤0.01% 1580
2018
Q4 		$1K Buy
+16
New +$2.03K ﹤0.01% 1663

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Meeder Asset Management's SER Position: Q4 2021 in Review

Meeder Asset Management sold out of Serina Therapeutics (SER) in Q4 2021, closing a stake of 3 shares.

Meeder Asset Management first reported a position in SER in Q4 2018 and held it in 11 quarters. The position peaked at $2K in Q4 2019. 35 funds tracked by Wall St. Rank hold SER as of Q4 2021.

  • Meeder Asset Management reported no remaining Serina Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 3 Serina Therapeutics shares in Q4 2021.
  • Meeder Asset Management first reported a position in Serina Therapeutics in Q4 2018 and held it in 11 quarters.
  • Meeder Asset Management's Serina Therapeutics position peaked at $2K in Q4 2019.
  • 35 funds tracked by Wall St. Rank held Serina Therapeutics as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.